Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity
Pharmacogenomics, 2016-09, Vol.17 (14), p.1483-1490
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial
European journal of cancer (1990), 2021-03, Vol.145, p.132-142
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
Clinical cancer research, 2018-02, Vol.24 (4), p.766-776
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
Clinical cancer research, 2018-06, Vol.24 (11), p.2678-2687
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study
European journal of cancer (1990), 2022-09, Vol.172, p.252-263
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors
Future oncology (London, England), 2021-07, Vol.17 (21), p.2747-2758
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Clinical cancer research, 2016-10, Vol.22 (20), p.5058-5067
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study
Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002447
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: Where does it fit?
European journal of cancer (1990), 2008-11, Vol.44 (16), p.2350-2356
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
Clinical cancer research, 2012-05, Vol.18 (9), p.2687-2694
2012
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial
Therapeutic advances in medical oncology, 2022-02, Vol.14, p.17588359221077088-17588359221077088
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma
Cancer chemotherapy and pharmacology, 2008-03, Vol.61 (3), p.435-441
2008
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials
The oncologist (Dayton, Ohio), 2013-03, Vol.18 (3), p.323-329
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Polymorphisms in
Pharmacogenomics, 2016-09, Vol.17 (14), p.1483-1490
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prophylaxis of Irinotecan‐Induced Diarrhea with Neomycin and Potential Role for UGT1A128 Genotype Screening: A Double‐Blind, Randomized, Placebo‐Controlled Study
The oncologist (Dayton, Ohio), 2006-09, Vol.11 (8), p.944-954
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951)
Future oncology (London, England), 2013-01, Vol.9 (1), p.13-20
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies
Clinical cancer research, 2005-10, Vol.11 (19), p.6908-6915
2005
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
Translational andrology and urology, 2012-12, Vol.1 (4), p.207-208
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract A92: A phase 1 safety and pharmacokinetic study of navitoclax in combination with docetaxel in patients with solid tumors
Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A92-A92
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors
Clinical cancer research, 2005-02, Vol.11 (4), p.1504-1511
2005
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract A15: A phase I and pharmacokinetic study of the vascular disrupting agent AVE8062 in combination with docetaxel, administered once every 3 weeks to patients with advanced solid tumors
Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A15-A15
2009
Volltextzugriff (PDF)
1 – 21 von 21
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen